Eugene Williams

Form D signer

Eugene Williams

President of the Issuer at Autoimmunity Biologic Solutions

Form D signer

Capital raised by Autoimmunity Biologic Solutions

$3.2M+$3.2M latest round

1 Form D filing · first filed Nov 2024 · Houston, TX

CURRENT ROLE: President of the Issuer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 1 ↗

Career

1 company on file

Autoimmunity Biologic SolutionsBiotech · Houston, TXsince Nov 2024

President of the Issuer

Signatory on Autoimmunity Biologic Solutions's Form D filings · $3.2M raised across 1

Company filings

via EDGAR · Form D for Autoimmunity Biologic Solutions1

DateCompanyFormAmountRole on filing

Nov 8, 2024Autoimmunity Biologic SolutionsForm D/A+$3.2MPresident of the Issuer

Form D/ANov 8, 2024 · Autoimmunity Biologic Solutions+$3.2Mas President of the Issuer

Overview

Last filing Nov 8, 2024

Eugene Williams is on file as President of the Issuer at Autoimmunity Biologic Solutions in Houston, TX. Autoimmunity Biologic Solutions has 1 Form D filing on record, $3.2M raised in total. Eugene Williams appears as a signatory on the company's filings.

LinkedIn profile

Teammates

Autoimmunity Biologic Solutions · 1

Mariano Garcia-BlancoDirector

Products

Autoimmunity Biologic Solutions · 1

Anti-sIL7R monoclonal antibody programPreclinical biologic therapeutic

A preclinical, first-in-class series of monoclonal antibodies highly specific for soluble IL7 receptor (sIL7R), designed to normalize elevated sIL7R levels while leaving membrane-bound IL7R signaling intact.